
NYSEHealthcareMedical - Diagnostics & Research
أحدث البيانات المتاحة
259.88 US$
+1.00 US$ · +0.39%
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
الإغلاق السابق
259.88 US$
+1.00 US$ · +0.39%
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
نطاق اليوم
السعر الحالي 259.88 US$
نطاق 52 أسبوعًا
السعر الحالي 259.88 US$
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
نقاط GoAI
شراء
تقييم
90
قيمة جذابة جدًا
المشاعر
69
صعودي
المخاطر
43
مخاطر أعلى من المعتاد
الزخم
52
محايد
بحث كامل عن GoAI
تابع للاطلاع على أدلة ومحفزات ومخاطر أعمق.
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
نطاق اليوم
السعر الحالي 259.88 US$
نطاق 52 أسبوعًا
السعر الحالي 259.88 US$
الربحية كنسبة مئوية من الإيرادات المعلنة.
الإيرادات
الدخل التشغيلي
صافي الدخل
| البند (USD) | السنة المالية 2025 | السنة المالية 2024 | السنة المالية 2023 | السنة المالية 2022 | السنة المالية 2021 |
|---|---|---|---|---|---|
| الإيرادات | 16.31 مليار USD | 15.41 مليار USD | 14.98 مليار USD | 14.41 مليار USD | 13.87 مليار USD |
| تكلفة البضاعة المباعة | 10.88 مليار USD | 10.03 مليار USD | 9.75 مليار USD | 9.38 مليار USD | 9.23 مليار USD |
| الربح الإجمالي | 5.43 مليار USD | 5.38 مليار USD | 5.24 مليار USD | 5.03 مليار USD | 4.64 مليار USD |
| مصاريف البيع والمصاريف العمومية والإدارية | 1.99 مليار USD | 1.99 مليار USD | 2.05 مليار USD | 2.07 مليار USD | 1.96 مليار USD |
| نفقات التشغيل | 3.25 مليار USD | 3.17 مليار USD | 3.26 مليار USD | 3.23 مليار USD | 3.25 مليار USD |
| دخل الفوائد | 45 مليون USD | 47 مليون USD | 36 مليون USD | 13 مليون USD | 6 مليون USD |
| مصاريف الفوائد | 729 مليون USD | 670 مليون USD | 672 مليون USD | 416 مليون USD | 375 مليون USD |
| الاستهلاك والإطفاء | 640 مليون USD | 1.11 مليار USD | 1.13 مليار USD | 1.13 مليار USD | 1.26 مليار USD |
| الدخل التشغيلي | 2.18 مليار USD | 2.2 مليار USD | 1.98 مليار USD | 1.8 مليار USD | 1.39 مليار USD |
| صافي الدخل | 1.36 مليار USD | 1.37 مليار USD | 1.36 مليار USD | 1.09 مليار USD | 966 مليون USD |
تم تحديث حقائق الشركة 11 أكتوبر 2026.
أحدث النتائج المعلنة
أحدث النتائج المعلنة
قد تتغير تقديرات المحللين الخارجيين، وهي ليست توصيات من GoAI.
متوسط الهدف
282.8 US$
ارتفاع محتمل بنسبة 8.82%صناديق متداولة تفصح عن تعرضها لهذا السهم.
State Street SPDR S&P 500 ETF1557.T82.11 مليار0.06%129.35 ترليون JPY0.09%122,850 JP¥+0.12%
Vanguard Morningstar Total Stock Market ETFVTI1.39 مليار0.06%2.3 ترليون USD0.03%381.94 US$+0.63%
Vanguard S&P 500 ETFVOO1.16 مليار0.07%1.8 ترليون USD0.03%715.59 US$+0.61%
Vanguard Morningstar Mid-Cap ETFVO942.93 مليون0.42%226.4 مليار USD0.03%81.14 US$+0.92%
iShares Core S&P 500 ETFIVV566.37 مليون0.06%896.44 مليار USD0.03%781.97 US$+0.60%
State Street SPDR S&P 500 ETFSPY518.64 مليون0.06%817.2 مليار USD0.09%778.57 US$+0.60%
Vanguard Morningstar Value ETFVTV416.53 مليون0.16%262.4 مليار USD0.03%220.59 US$+0.44%
State Street Health Care Select Sector SPDR ETFXLV303.45 مليون0.70%43.54 مليار USD0.08%170.81 US$+1.58%
State Street SPDR S&P 500 ETF1557.T
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard S&P 500 ETFVOO
Vanguard Morningstar Mid-Cap ETFVO
iShares Core S&P 500 ETFIVV
State Street SPDR S&P 500 ETFSPY
Vanguard Morningstar Value ETFVTV
State Street Health Care Select Sector SPDR ETFXLVالمحتوى المُنشأ بالذكاء الاصطناعي وبيانات السوق المتأخرة لأغراض معلوماتية وتعليمية فقط، ولا تُعد نصيحة استثمارية.